Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting
GERMANTOWN, Md., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable ...
Yahoo Finance22d
Senseonics Stock Surges 42% After Hours on Preliminary Revenue Report
Through Ascensia Diabetes Care, a commercial partner, Senseonics introduced the device in the United States. While the number of American prescribers hit 1,000 in 2024, the worldwide patient ...
Business Wire1mon
$52.46 Bn Blood Glucose Monitoring Devices Focused Market Insights 2024-2029: Next-generation Blood Glucose Monitoring Systems, Flash Glucose Monitoring, Government Initiatives ...
F. Hoffmann-La Roche, Abbott, Dexcom, Medtronic, Ascensia Diabetes Care Holdings AG, and LifeScan IP Holdings are some leading companies dominating the conventional BGM devices segment.